Shares of Halyard Health, Inc. (NYSE:HYH) have received an average recommendation of “Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $42.25.
Several equities analysts have recently weighed in on HYH shares. TheStreet raised Halyard Health from a “c” rating to a “b” rating in a research note on Thursday, June 22nd. BidaskClub lowered Halyard Health from a “buy” rating to a “hold” rating in a research note on Saturday, July 8th. Stephens raised Halyard Health from an “equal weight” rating to an “overweight” rating in a research note on Thursday, August 3rd. Deutsche Bank AG lifted their price objective on Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research note on Thursday, August 3rd. Finally, Zacks Investment Research raised Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 price objective on the stock in a research note on Wednesday, July 12th.
A number of institutional investors have recently added to or reduced their stakes in HYH. CENTRAL TRUST Co raised its position in Halyard Health by 1.0% in the first quarter. CENTRAL TRUST Co now owns 2,643 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 25 shares during the period. Meadow Creek Investment Management LLC raised its position in Halyard Health by 1.1% in the first quarter. Meadow Creek Investment Management LLC now owns 2,660 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 28 shares during the period. Glen Harbor Capital Management LLC raised its position in Halyard Health by 1.1% in the first quarter. Glen Harbor Capital Management LLC now owns 3,230 shares of the medical instruments supplier’s stock valued at $123,000 after buying an additional 34 shares during the period. Patten Group Inc. raised its position in Halyard Health by 0.4% in the first quarter. Patten Group Inc. now owns 19,629 shares of the medical instruments supplier’s stock valued at $769,000 after buying an additional 75 shares during the period. Finally, Amalgamated Bank raised its position in Halyard Health by 1.2% in the second quarter. Amalgamated Bank now owns 6,655 shares of the medical instruments supplier’s stock valued at $261,000 after buying an additional 82 shares during the period. 90.32% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Halyard Health (HYH) traded up 0.95% during mid-day trading on Friday, hitting $42.30. 271,246 shares of the stock traded hands. The company has a market cap of $1.98 billion, a P/E ratio of 40.67 and a beta of 1.78. Halyard Health has a one year low of $31.59 and a one year high of $43.78. The stock has a 50 day moving average price of $40.23 and a 200-day moving average price of $38.87.
Halyard Health (NYSE:HYH) last released its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.14. The business had revenue of $399.20 million for the quarter, compared to analyst estimates of $399.16 million. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The company’s revenue was down .2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.45 EPS. On average, analysts forecast that Halyard Health will post $1.98 earnings per share for the current fiscal year.
Halyard Health Company Profile
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
